Based on CDKN1A and SIRT1 expression, the diagnostic model constructed was also determined to be able to distinguish NASH patients from normal individuals with high specificity and high sensitivity. The gene discussed is CDKN1A; the disease is metabolic dysfunction-associated steatohepatitis.